In this Trending News Europe episode, Jack, Jen, and Ollie discuss a few recent newsworthy items, including an increase in cyberattacks on the healthcare sector, Europe’s plan to future-proof its Biotech Sector and New Research from the University of Oxford into psilocybin as a potential treatment for depression. 

Podcast Tags: healthcare, healthcare news, life sciences, NHS, cybersecurity, biotech, research & development, pharmaceuticals, depression, psilocybin, mental health, psychedelics, mental health awareness week 

Source Links: 

• ’Large volume’ of data stolen from NHS Dumfries and Galloway published on dark web 
• Huge volume of NHS patient and staff data released by hacker 
• NHS cyber attack: Why stolen medical information is so much more valuable than financial data 
• Cyber attacks are one of the biggest threats facing healthcare systems 
• Government Launches NHS Cyber Security Strategy 
• US tech group Palantir wins lucrative NHS data contract 
• Patient privacy fears as US spy tech firm Palantir wins £330m NHS contract 
• European Commission lays down path to future-proof EU biotechnology 
• Roche to buy Carmot for up to $3.1bn as race for obesity drugs intensifies 
• Roche agrees $7.1bn deal for Telavant to boost drug pipeline  
• Europe’s biotech innovation in the balance 
• Commission takes action to boost biotechnology and biomanufacturing in the EU 
• Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis 
• EU launches landmark €6.5M study on use of psychedelics to treat mental disorders 
• Magic mushrooms’ psilocybin can alleviate severe depression when used with therapy 
• Psychedelic drug research held back by UK rules and attitudes, say scientists 
• King’s College Psychoactive Trials Group 

Panel – Jack Young, Jen Burke, Ollie May 

Research & Production – Karan Pandya, Jack Young 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.